This is the authors' abstract. We don't add key points for this paper.
in the United States is incompletely described. Using a PCR assay targeting common mutations associated with macrolide resistance in M. pneumoniae (23S rRNA gene, A2063G/A2064G), the frequency of macrolide resistance was estimated to be 10% based on analysis of 114 samples tested from January 2014 to September 2021 at Mayo Clinic Laboratories. Seasonality data showed the highest rates of M. pneumoniae infection in the fall/early winter.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rothstein et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: